Explore News
-
How short-term fasting boosts ovarian cancer treatment
Short-term fasting may improve chemo response in ovarian cancer
-
Breakthrough in Ovarian Cancer Treatment Reveals New Hope
A promising new approach to tackling ovarian cancer’s resistance to chemotherapy
-
Endometriosis Linked to Higher Cancer Risk, Study Reveals
New research from the University of Aberdeen suggests endometriosis may significantly raise a woman’s risk…
-
Talcum Powder Lawsuits Against Johnson & Johnson Surge to 7,000 Claimants
Johnson & Johnson faces largest product liability case in UK history
-
Johnson & Johnson Talcum Powder Case Sees Claimant Numbers Surge to 7,000
The number of claimants in the Johnson & Johnson talcum powder case has more than…
-
What Drives the Success of Combination Therapy in HER2-Expressing Malignancies
A phase 1 study shows tolerable dosing schedule with promising activity for HER2-expressing malignancies
-
Why GSK’s New Cancer Drug is Causing a Stir
New treatment shows significant promise in reducing tumors
-
New Hope for Patients with Platinum-Resistant Ovarian Cancer
Clinical trial reveals promising results for Relacorilant in treating aggressive ovarian cancer
